Author

Nagai N

Kindai University - Cited by 2,348 - Pharmaceutical technology - Nanomedicine

Biography

Nagai N is working in the Department of Pharmacy, Kinki University, Kowakae, Higashi-Osaka, Osaka, Japan. His international experience includes various programs, contributions, and participation in different countries for diverse fields of study. His research interests reflect in his wide range of publications in various national and international journals. He is the Editorial Board Member of many journals and serves as a member of various associations, apart from being an author for many books.
Title
Cited by
Year
Novel drug delivery systems for the management of dry eye
N Nagai, H OtakeAdvanced Drug Delivery Reviews, 114582, 2022202
12
2022
Nanocrystalline suspensions of irbesartan enhance oral bioavailability by improving drug solubility and leading endocytosis uptake into the intestine
S Deguchi, F Ogata, M Watanabe, H Otake, N Yamamoto, N Kawasaki, ...Pharmaceutics 13 (9), 1404, 2021202
8
2021
Regulation of the membrane trafficking of the mechanosensitive ion channels TRPV1 and TRPV4 by Zonular tension, osmotic stress and activators in the mouse lens
Y Nakazawa, RS Petrova, Y Sugiyama, N Nagai, H Tamura, ...International journal of molecular sciences 22 (23), 1265, 2021202
8
2021
Energy-dependent endocytosis is responsible for skin penetration of formulations based on a combination of indomethacin nanoparticles and L-menthol in rat and göttingen minipig
H Otake, M Yamaguchi, F Ogata, S Deguchi, N Yamamoto, H Sasaki, ...International journal of molecular sciences 22 (10), 513, 2021202
7
2021
Fixed-combination eye drops based on fluorometholone nanoparticles and bromfenac/levofloxacin solution improve drug corneal penetration
H Otake, R Goto, F Ogata, T Isaka, N Kawasaki, S Kobayakawa, ...International Journal of Nanomedicine, 5343-5356, 2021202
7
2021
Fenofibrate nano-eyedrops ameliorate retinal blood flow dysregulation and neurovascular coupling in type 2 diabetic mice
J Hanaguri, N Nagai, H Yokota, A Kushiyama, M Watanabe, S Yamagami, ...Pharmaceutics 14 (2), 384, 2022202
7
2022
Balance of drug residence and diffusion in lacrimal fluid determine ocular bioavailability in in situ gels incorporating tranilast nanoparticles
M Minami, H Otake, Y Nakazawa, N Okamoto, N Yamamoto, H Sasaki, ...Pharmaceutics 13 (9), 142, 2021202
5
2021
Minoxidil nanoparticles targeting hair follicles enhance hair growth in C57BL/6 mice
Minoxidil nanoparticles targeting hair follicles enhance hair growth in C7BL/6 miceY Oaku, A Abe, Y Sasano, F Sasaki, C Kubota, N Yamamoto, ...Pharmaceutics 14 (), 947, 2022202
5
2022
Capsaicin attenuates TGFβ2-induced epithelial-mesenchymal-transition in lens epithelial cells in vivo and in vitro
Y Sugiyama, Y Nakazawa, T Sakagami, S Kawata, N Nagai, N Yamamoto, ...Experimental Eye Research 213, 108840, 2021202
5
2021
In vitro removal of paraquat and diquat from aqueous media using raw and calcined basil seed
Y Uematsu, F Ogata, N Nagai, C Saenjum, T Nakamura, N KawasakiHeliyon 7 (7), 2021202
4
2021
Oral formulation based on irbesartan nanocrystals improve drug solubility, absorbability, and efficacy
N Nagai, F Ogata, A Ike, Y Shimomae, H Osako, Y Nakazawa, ...Pharmaceutics 1 (2), 387, 2022202
4
2022
Differences in a single extracellular residue underlie adhesive functions of two zebrafish Aqp0s
I Vorontsova, JE Hall, TF Schilling, N Nagai, Y NakazawaCells 10 (8), 2005, 2021202
3
2021
ストレプトゾトシン誘発糖尿病ラットの水晶体構造異常に対するニルバジピンナノ分散液の保護効果
後藤涼花， 山田茂裕， 馬地一稀， 竹中晴菜， 平松範子， 山本直樹， ...日本白内障学会誌 34 (), 6-65, 2022202
1
2022
Magnesium Hydroxide Nanoparticles Improve the Ocular Hypotensive Effect of Twice Daily Topical Timolol Maleate in Healthy Dogs
M Kita, K Kanai, H Mitsuhashi, T Noguchi, N Nagai, M Yamaguchi, ...Veterinary Sciences 8 (8), 68, 20220
1
2021
Retention, Bacterial Adhesion, and Biofilm Formation between Anionic and Zwitterionic Bandage Contact Lenses in Healthy Dogs: A Pilot Study
M Kita, K Kanai, HK Ono, Y Otaka, D Okada, N Nagai, R Kudo, ...Veterinary Sciences 8 (0), 238, 20220
1
2021
Instillation of ophthalmic formulation containing nilvadipine nanocrystals attenuates lens opacification in shumiya cataract rats
R Goto, S Yamada, H Otake, Y Nakazawa, M Oka, N Yamamoto, H Sasaki, ...Pharmaceutics 3 (2), 999, 20220
1
2021
Role of mucoadhesive agent in ocular delivery of ganciclovir microemulsion: cytotoxicity evaluation in vitro and ex vivo
M Choudhari, K Nayak, N Nagai, Y Nakazawa, D Khunt, M MisraInternational Ophthalmology 43 (4), 53-67, 2023202
1
2023
Optimization of the Hydrothermal Activation Treatment with Sodium Hydroxide Solution for the Conversion of Coal Fly Ash to Zeolite and Its Adsorption Capability of Lead (II …
F Ogata, N Nagai, M Funaki, A Tabuchi, Y Kobayashi, C Saenjum, ...Chemical and Pharmaceutical Bulletin 70 (5), 400-407, 2022202
1
2022
N,N-Diethyl-3-toluamide Formulation Based on Ethanol Containing 0.1% 2-Hydroxypropyl-β-cyclodextrin Attenuates the Drug’s Skin Penetration and Prolongs the …
N,N-Diethyl-3-toluamide Formulation Based on Ethanol Containing 0.% 2-Hydroxypropyl-β-cyclodextrin Attenuates the Drug’s Skin Penetration and Prolongs the …N Nagai, M Kawaguchi, M Minami, K Matsumoto, T Sasabe, K Nobuhara, ...Molecules 27 (0), 374, 2022202
1
2022
Combination of lanosterol and nilvadipine nanosuspensions rescues lens opacification in selenite-induced cataractic rats
S Deguchi, R Kadowaki, H Otake, A Taga, Y Nakazawa, M Misra, ...Pharmaceutics 4 (7), 520, 2022202
1
2022

Referred From: https://scholar.google.com/citations?hl=en&user=r9QXRMIAAAAJ

Cited by
Citations 2348
h-index 26
i10-index 88
Open Access Journals